Gregory Riedlinger

3.3k total citations · 1 hit paper
54 papers, 1.9k citations indexed

About

Gregory Riedlinger is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gregory Riedlinger has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Gregory Riedlinger's work include Cancer Genomics and Diagnostics (15 papers), AI in cancer detection (8 papers) and Genetic factors in colorectal cancer (5 papers). Gregory Riedlinger is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), AI in cancer detection (8 papers) and Genetic factors in colorectal cancer (5 papers). Gregory Riedlinger collaborates with scholars based in United States, Japan and Netherlands. Gregory Riedlinger's co-authors include Lothar Hennighausen, Keiko Miyoshi, Yongzhi Cui, Gertraud W. Robinson, Wei Tang, Chu‐Xia Deng, Cuiling Li, Shridar Ganesan, Edmund B. Rucker and Kay‐Uwe Wagner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gregory Riedlinger

53 papers receiving 1.9k citations

Hit Papers

Real-world application of tumor mutational burden-high (T... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
    2021 196 citations Salma K. Jabbour, Shridar Ganesan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Riedlinger United States 22 749 728 453 380 321 54 1.9k
Kris Ylaya United States 25 816 1.1× 1.0k 1.4× 444 1.0× 527 1.4× 362 1.1× 45 2.0k
Jiansong Ji China 26 557 0.7× 904 1.2× 389 0.9× 548 1.4× 348 1.1× 82 2.2k
Younghee Lee United States 23 629 0.8× 1.0k 1.4× 518 1.1× 369 1.0× 258 0.8× 93 2.4k
Ann Marie Egloff United States 29 837 1.1× 1.2k 1.7× 324 0.7× 371 1.0× 430 1.3× 63 2.3k
Chengyun Zheng China 28 680 0.9× 855 1.2× 1.1k 2.5× 429 1.1× 227 0.7× 71 2.6k
Deborah J. Wong United States 20 1.0k 1.4× 1.2k 1.6× 531 1.2× 345 0.9× 503 1.6× 79 2.4k
Kun Mu China 23 419 0.6× 949 1.3× 293 0.6× 310 0.8× 222 0.7× 59 1.6k
Xinhui Wang United States 21 917 1.2× 828 1.1× 536 1.2× 459 1.2× 251 0.8× 55 1.9k

Countries citing papers authored by Gregory Riedlinger

Since Specialization
Citations

This map shows the geographic impact of Gregory Riedlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Riedlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Riedlinger more than expected).

Fields of papers citing papers by Gregory Riedlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Riedlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Riedlinger. The network helps show where Gregory Riedlinger may publish in the future.

Co-authorship network of co-authors of Gregory Riedlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Riedlinger. A scholar is included among the top collaborators of Gregory Riedlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Riedlinger. Gregory Riedlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berim, Lyudmyla, et al.. (2025). Occult collision tumor of the gastroesophageal junction comprising adenocarcinomas with distinct molecular profiles. Cancer Genetics. 292-293. 27–34. 1 indexed citations
2.
Kohli, Manish, Gregory Riedlinger, Eric A. Singer, et al.. (2024). Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations. Clinical Genitourinary Cancer. 23(1). 102293–102293. 1 indexed citations
3.
Lu, Wen, Yong Tang, Clotilde Wiel, et al.. (2023). SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity. Oncogene. 42(27). 2183–2194. 8 indexed citations
4.
Biswas, Antara, Sarthak Sahoo, Gregory Riedlinger, et al.. (2023). Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma. Communications Biology. 6(1). 1292–1292. 7 indexed citations
5.
Kwon, Mijung, Haitao Wang, Gregory Riedlinger, et al.. (2022). Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis. Cancer Research Communications. 2(10). 1197–1213. 8 indexed citations
6.
Shaheen, Montaser, Julie Y. Tse, Ethan Sokol, et al.. (2022). Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial. eLife. 11. 9 indexed citations
7.
Matsuda, Kant, Gregory Riedlinger, Levi Sokol, et al.. (2021). Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer. Case Reports in Oncology. 14(2). 931–937. 10 indexed citations
8.
Riedlinger, Gregory, Sonali Joshi, Kim M. Hirshfield, Nicola Barnard, & Shridar Ganesan. (2021). Targetable alterations in invasive pleomorphic lobular carcinoma of the breast. Breast Cancer Research. 23(1). 7–7. 13 indexed citations
9.
Riedlinger, Gregory, et al.. (2019). All-FIT: allele-frequency-based imputation of tumor purity from high-depth sequencing data. Bioinformatics. 36(7). 2173–2180. 8 indexed citations
10.
Malhotra, Jyoti, Salma K. Jabbour, Gregory Riedlinger, et al.. (2019). Phase Ib/II study of hydroxychloroquine in combination with chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC). Cancer Treatment and Research Communications. 21. 100158–100158. 52 indexed citations
11.
Hipp, Jason, Donald J. Johann, Yun Chen, et al.. (2018). Computer-Aided Laser Dissection: A Microdissection Workflow Leveraging Image Analysis Tools. Journal of Pathology Informatics. 9(1). 45–45. 9 indexed citations
12.
Morgan, Katherine M., Gregory Riedlinger, Jeffrey Rosenfeld, Shridar Ganesan, & Sharon R. Pine. (2017). Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine. Frontiers in Oncology. 7. 2–2. 57 indexed citations
13.
Rodríguez-Rodríguez, Lorna, Kim M. Hirshfield, Verónica Rojas, et al.. (2016). Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers. Gynecologic Oncology. 141(1). 2–9. 25 indexed citations
14.
Klepeis, Veronica, Diana Mandelker, Gregory Riedlinger, et al.. (2014). The ongoing evolution of the core curriculum of a clinical fellowship in pathology informatics. Journal of Pathology Informatics. 5(1). 22–22. 6 indexed citations
15.
Mandelker, Diana, Gregory Riedlinger, Veronica Klepeis, et al.. (2014). Pathology informatics fellowship training: Focus on molecular pathology. Journal of Pathology Informatics. 5(1). 11–11. 3 indexed citations
16.
Riedlinger, Gregory, et al.. (2010). The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction. BMC Cancer. 10(1). 179–179. 15 indexed citations
17.
18.
Riedlinger, Gregory, Ryugo Okagaki, Kay‐Uwe Wagner, et al.. (2002). Bcl-x Is Not Required for Maintenance of Follicles and Corpus Luteum in the Postnatal Mouse Ovary1. Biology of Reproduction. 66(2). 438–444. 23 indexed citations
19.
Miyoshi, Keiko, Yongzhi Cui, Gregory Riedlinger, et al.. (2001). Structure of the Mouse Stat 3/5 Locus: Evolution from Drosophila to Zebrafish to Mouse. Genomics. 71(2). 150–155. 51 indexed citations
20.
Riedlinger, Gregory, et al.. (1980). [Non-invasive studies on the cardiac effect of low digitoxin maintenance doses (author's transl)].. PubMed. 69(4). 296–306. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kris Ylaya Breakdown of academic impact, for papers by Jiansong Ji Breakdown of academic impact, for papers by Younghee Lee Breakdown of academic impact, for papers by Ann Marie Egloff Breakdown of academic impact, for papers by Chengyun Zheng Breakdown of academic impact, for papers by Deborah J. Wong Breakdown of academic impact, for papers by Kun Mu Breakdown of academic impact, for papers by Xinhui Wang
Rankless by CCL
2026